Values First Advisors, Inc. Bio Line Rx Ltd. Transaction History
Values First Advisors, Inc.
- $177 Million
- Q4 2024
A detailed history of Values First Advisors, Inc. transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Values First Advisors, Inc. holds 166,449 shares of BLRX stock, worth $575,913. This represents 0.02% of its overall portfolio holdings.
Number of Shares
166,449
Previous 197,516
15.73%
Holding current value
$575,913
Previous $106,000
66.04%
% of portfolio
0.02%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding BLRX
# of Institutions
39Shares Held
4.24MCall Options Held
46.5KPut Options Held
6.3K-
Highbridge Capital Management LLC New York, NY1.01MShares$3.49 Million0.05% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL866KShares$3 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE816KShares$2.82 Million4.05% of portfolio
-
Morgan Stanley New York, NY198KShares$683,4780.0% of portfolio
-
Pvg Asset Management Corp Golden, CO157KShares$543,9630.37% of portfolio
About BioLineRx Ltd.
- Ticker BLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 61,524,500
- Market Cap $213M
- Description
- BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...